Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MindMed
Recent news which mentions MindMed
New Meme MindMed Executes 1:15 Reverse Stock Split
August 29, 2022
Tickers
MNMD
Tags
News
Market News
Stock Split
From
Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
Tags
Small Cap
Robert Barrow
MNMD
From
Benzinga
MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance
May 19, 2022
Tickers
MNMD
Tags
News
Penny Stocks
Cannabis
From
Benzinga
Can LSD Treat Anxiety? MindMed's New Topline Data Show Promise, Here's The Research
May 12, 2022
Tickers
MNMD
Tags
MNMD
News
University Hospital Basel Liechti Lab
From
Benzinga
EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences
April 27, 2022
Tickers
CCHWF
JUSHF
MNMD
WING
Tags
Dan Gilbert
Leonardo Dicaprio
Groot Hospitality
From
Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Markets
Market News
Cannabis
From
Benzinga
MindMed Reports Full Year 2021 Financial Results, Announces Changes In Leadership
March 28, 2022
Tickers
MNMD
Tags
Penny Stocks
News
Cannabis
From
Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Tickers
CYBN
ENVB
FTRP
MNMD
Tags
CYBN
April19
Small Cap
From
Benzinga
MindMed Successfully Completes Phase 1 Trial Of 18-MC
January 19, 2022
Tickers
MNMD
Tags
clinical trial
Markets
Cannabis
From
Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
Tags
News
MNMD
Benzinga
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
J/R/ Rahn
MindMed
Interview
From
Benzinga
How This Company Is Using Psychedelic Medicines and Therapies to Treat Addiction and Mental Illness
November 02, 2021
Tickers
MNMD
TSLA
Tags
Markets
Partner Content
MMED
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
Exclusives
$LTC
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.